The startup offers a decentralized autonomous organization platform that facilitates collective funding and digitization of longevity research through intellectual property non-fungible tokens. By connecting researchers with a community of longevity scientists, the platform accelerates the development of biotech companies focused on extending human life and health span.
Funding
$500K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Longevity research often faces funding gaps between academic discovery and commercialization, hindering the development of therapeutics and interventions targeting age-related diseases. Individual researchers may lack the resources and networks to translate their findings into viable biotech companies.
Solution
VitaDAO is a decentralized autonomous organization (DAO) that facilitates collective funding and community-driven governance of longevity research. The platform connects researchers with a global network of scientists, entrepreneurs, and investors, providing access to funding, expertise, and resources needed to advance their projects. VitaDAO utilizes intellectual property non-fungible tokens (IP-NFTs) to digitize and manage ownership of research outputs, enabling a more transparent and efficient system for funding and commercializing longevity-focused innovations. By democratizing access to funding and intellectual property, VitaDAO aims to accelerate the development of novel therapeutics and interventions that extend human healthspan.
Target Audience
The primary target audience includes longevity researchers, biotech entrepreneurs, investors interested in the longevity field, and individuals seeking to contribute to the advancement of healthy aging.
Features
- Decentralized platform for funding longevity research projects through community governance.
- IP-NFTs for transparent management and fractional ownership of intellectual property.
- Access to a global network of longevity scientists, biotech entrepreneurs, and investors.
- Funding opportunities for projects at various stages, from early-stage research to pre-clinical development.
- Support for translational R&D with a focus on therapeutics, interventions, diagnostics, and biomarkers targeting aging and age-related diseases.
- VitaLabs fellowship program providing stipends, resources, and mentorship for researchers.
- Governance forum for community members to propose and vote on funding decisions.